deltatrials
Active Not Recruiting OBSERVATIONAL NCT05476926

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER)

Real-World, Long-Term Data Collection to Gain Clinical Insights Into Roche Ophthalmology Products (VOYAGER STUDY)

Sponsor: Hoffmann-La Roche

Conditions Branch Retinal Vein Occlusion Central Retinal Vein Occlusion Diabetic Macular Edema Hemi-retinal Vein Occlusion Neovascular Age-related Macular Degeneration Retinal Vein Occlusion
Interventions Faricimab Port Delivery System with Ranibizumab
Updated 39 times since 2022 Last updated: Dec 15, 2025 Started: Nov 21, 2022 Primary completion: Mar 31, 2027 Completion: Nov 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Branch Retinal Vein Occlusion and Central Retinal Vein Occlusion and is currently ongoing. Hoffmann-La Roche leads this study, which shows 39 recorded versions since 2022 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Mar 2024 · 29 days · monthly snapshot~Mar 2024 – ~Apr 2024 · 31 days · monthly snapshot~Apr 2024 – ~May 2024 · 30 days · monthly snapshot~May 2024 – ~Jun 2024 · 31 days · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Dec 2024 · 30 days · monthly snapshot~Dec 2024 – ~Jan 2025 · 31 days · monthly snapshot~Jan 2025 – ~Feb 2025 · 31 days · monthly snapshot~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Aug 2025 · 31 days · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – ~Nov 2025 · 31 days · monthly snapshot~Nov 2025 – ~Dec 2025 · 30 days · monthly snapshot~Dec 2025 – ~Jan 2026 · 31 days · monthly snapshot~Jan 2026 – present · 7 months · monthly snapshot

Change History

39 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  2. Dec 2025 — Jan 2026 [monthly]

    Recruiting

  3. Nov 2025 — Dec 2025 [monthly]

    Recruiting

  4. Oct 2025 — Nov 2025 [monthly]

    Recruiting

  5. Sep 2025 — Oct 2025 [monthly]

    Recruiting

▶ Show 34 earlier versions

  1. Aug 2025 — Sep 2025 [monthly]

    Recruiting

  2. Jul 2025 — Aug 2025 [monthly]

    Recruiting

  3. Jun 2025 — Jul 2025 [monthly]

    Recruiting

  4. May 2025 — Jun 2025 [monthly]

    Recruiting

  5. Apr 2025 — May 2025 [monthly]

    Recruiting

  6. Mar 2025 — Apr 2025 [monthly]

    Recruiting

  7. Feb 2025 — Mar 2025 [monthly]

    Recruiting

  8. Jan 2025 — Feb 2025 [monthly]

    Recruiting

  9. Dec 2024 — Jan 2025 [monthly]

    Recruiting

  10. Nov 2024 — Dec 2024 [monthly]

    Recruiting

  11. Oct 2024 — Nov 2024 [monthly]

    Recruiting

  12. Sep 2024 — Oct 2024 [monthly]

    Recruiting

  13. Aug 2024 — Sep 2024 [monthly]

    Recruiting

  14. Jul 2024 — Aug 2024 [monthly]

    Recruiting

  15. Jun 2024 — Jul 2024 [monthly]

    Recruiting

  16. May 2024 — Jun 2024 [monthly]

    Recruiting

  17. Apr 2024 — May 2024 [monthly]

    Recruiting

  18. Mar 2024 — Apr 2024 [monthly]

    Recruiting

  19. Feb 2024 — Mar 2024 [monthly]

    Recruiting

  20. Jan 2024 — Feb 2024 [monthly]

    Recruiting

  21. Dec 2023 — Jan 2024 [monthly]

    Recruiting

  22. Nov 2023 — Dec 2023 [monthly]

    Recruiting

  23. Oct 2023 — Nov 2023 [monthly]

    Recruiting

  24. Sep 2023 — Oct 2023 [monthly]

    Recruiting

  25. Aug 2023 — Sep 2023 [monthly]

    Recruiting

  26. Jul 2023 — Aug 2023 [monthly]

    Recruiting

  27. Jun 2023 — Jul 2023 [monthly]

    Recruiting

  28. May 2023 — Jun 2023 [monthly]

    Recruiting

  29. Apr 2023 — May 2023 [monthly]

    Recruiting

  30. Feb 2023 — Apr 2023 [monthly]

    Recruiting

  31. Jan 2023 — Feb 2023 [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  32. Dec 2022 — Jan 2023 [monthly]

    Not Yet Recruiting

  33. Nov 2022 — Dec 2022 [monthly]

    Not Yet Recruiting

  34. Sep 2022 — Nov 2022 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hoffmann-La Roche
Data source: Hoffmann-La Roche

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Aarau, Switzerland , Abu Dhabi, United Arab Emirates , Acquaviva Delle Fonti, Italy , Aichi, Japan , Aix-en-Provence, France , Akita, Japan , Albacete, Spain , Amiens, France , Ancona, Italy and 235 more locations